Diagnosing heparin induced thrombocytopenia in critically ill patients

Intensive Care Medicine

Volumn 36, Issue 8, 2010, Pages 1447-1448

  Davies, J O J ^a   Patel, P ^a   Zoumot, Z ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; ANTICOAGULANT AGENT;

BLEEDING; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CRITICALLY ILL PATIENT; HEART SURGERY; HEPARIN INDUCED THROMBOCYTOPENIA; HIGH RISK PATIENT; HUMAN; INTENSIVE CARE UNIT; KIDNEY FAILURE; LABORATORY TEST; LETTER; PRACTICE GUIDELINE; PREDICTION; RENAL REPLACEMENT THERAPY; SCORING SYSTEM; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; CHEMICALLY INDUCED; CRITICAL ILLNESS; FEMALE; MALE; THROMBOCYTOPENIA;

ANTICOAGULANTS; CRITICAL ILLNESS; FEMALE; HEPARIN; HUMANS; MALE; THROMBOCYTOPENIA;

EID: 77956171988     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-010-1806-8     Document Type: Letter

References (4)

1. Warkentin TE, Greinacher A, Koster A,Lincoff AM (2008) Treatment andprevention of heparin-inducedthrombocytopenia: American College of Chest Physicians Evidence-BasedClinical Practice Guidelines (8th edn). Chest 133:340S-380S
2. Keeling D, Davidson S, Watson H(2006) The management of heparininducedthrombocytopenia. Br JHaematol 133:259-269
3. Warkentin TE, Heddle NM (2003)Laboratory diagnosis of immuneheparin-induced thrombocytopenia. CurrHematol Rep 2:148-157
4. Warkentin TE, Sheppard JA, HorsewoodP, Simpson PJ, Moore JC, Kelton JG(2000) Impact of the patient populationon the risk for heparin- inducedthrombocytopenia. Blood 96:1703-1708